Therapeutics: Glycinamide ribonucleotide formyltransferase (GARFT); folate receptor 1 (FOLR1; FR-α); FOLR2 (FR-β); solute carrier family 46 folate transporter m

Cancer

INDICATION: Cancer

Mouse and cell studies identified an inhibitor of GARFT, FOLR1, FOLR2 and SLC46A1 that could

Read the full 162 word article

How to gain access

Continue reading with a
two-week free trial.